HR 3520 · 119th Congress 2025โ€“2027

STAND Against Emerging Opioids Act

Latest action · May 20, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMay 20, 2025
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Cosponsors 2

Members who signed on, in the order they did. Signatures ran from May 20, 2025 to Jun 12, 2025; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
R-TXAugust PflugerOriginalMay 20, 2025
R-TNDavid KustoffJun 12, 2025

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred May 20, 2025
HouseJudiciary Committee
Referred May 20, 2025

Actions 2

Everything that happened, newest first.

  1. May 20, 2025Introduced in House
  2. May 20, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8, Clause 18

The sponsor’s statement, as printed in the Congressional Record, vol. 171, no. 85, May 20, 2025, page H2199.

Titles 3

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Controlled Substances Act to provide for the scheduling of tianeptine as a schedule III substance, and for other purposes.
Short Title(s) as Introduced
STAND Against Emerging Opioids Act
Scheduling Tianeptine and Analogues Now to Defend Against Emerging Opioids Act

Subjects

Assigned by the Library of Congress. Policy area: Crime and Law Enforcement.

Text 1

Each version as it was printed, newest first.

  1. May 20, 2025Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.